Detalhe da pesquisa
1.
Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32-week randomized trial.
Diabetes Obes Metab
; 26(5): 1624-1635, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240066
2.
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
Diabetologia
; 66(5): 813-825, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746803
3.
Evaluation of renal oxygenation by BOLD-MRI in high-risk patients with type 2 diabetes and matched controls.
Nephrol Dial Transplant
; 38(3): 691-699, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612982
4.
Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
Diabetologia
; 67(7): 1451, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739291
5.
The effects of semaglutide, empagliflozin and their combination on the kidney sodium signal from magnetic resonance imaging: A prespecified, secondary analysis from a randomized, clinical trial.
J Diabetes Complications
; 38(2): 108673, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38219335